Search Results - "Malmström, R. E."

Refine Results
  1. 1

    Effectiveness of Drugs in Routine Care: A Model for Sequential Monitoring of New Medicines Using Dronedarone as Example by Cars, T, Lindhagen, L, Malmström, RE, Neovius, M, Schwieler, J, Wettermark, B, Sundström, J

    Published in Clinical pharmacology and therapeutics (01-03-2018)
    “…Although there is no doubt about the scientific value of randomized controlled clinical trials, they are usually conducted in selected populations different…”
    Get full text
    Journal Article
  2. 2

    Rapid determination of anticoagulating effects of dabigatran in whole blood with rotational thromboelastometry and a thrombin‐based trigger by Taune, V., Skeppholm, M., Ågren, A., Gryfelt, G., Malmström, R. E., Wikman, A., Van Ryn, J., Wallén, H.

    Published in Journal of thrombosis and haemostasis (01-12-2018)
    “…Essentials A rapid test to detect thrombin inhibition by dabigatran would be valuable in acute situations. A thrombin‐based trigger was applied in whole blood…”
    Get full text
    Journal Article
  3. 3

    Thrombin‐reduced miR‐27b attenuates platelet angiogenic activities in vitro via enhancing platelet synthesis of anti‐angiogenic thrombospondin‐1 by Miao, X., Rahman, M. F.‐U., Jiang, L., Min, Y., Tan, S., Xie, H., Lee, L., Wang, M., Malmström, R. E., Lui, W.‐O., Li, N.

    Published in Journal of thrombosis and haemostasis (01-04-2018)
    “…Essentials It is unclear if platelet micro‐RNAs can regulate de novo protein synthesis of platelets. Platelet de novo protein synthesis of thrombospondin‐1…”
    Get full text
    Journal Article
  4. 4

    Influence of multiple initiatives in Sweden to enhance ARB prescribing efficiency following generic losartan; findings and implications for other countries by Godman, B, Wettermark, B, Miranda, J, Bennie, M, Martin, A, Malmström, R E

    “…Encouraging the prescribing of ACEIs first line vs. angiotensin receptor blockers (ARBs) has been a health authority focus with generic ACEIs as ACEIs and ARBs…”
    Get more information
    Journal Article
  5. 5

    l -Arginine and tetrahydrobiopterin protects against ischemia/reperfusion-induced endothelial dysfunction in patients with type 2 diabetes mellitus and coronary artery disease by Settergren, M, Böhm, F, Malmström, R.E, Channon, K.M, Pernow, J

    Published in Atherosclerosis (01-05-2009)
    “…Abstract Diminished levels of l -arginine and endothelial nitric oxide synthase (eNOS) uncoupling through deficiency of tetrahydrobiopterin (BH4 ) may…”
    Get full text
    Journal Article
  6. 6

    Comparison of calibrated dilute thrombin time and aPTT tests with LC-MS/MS for the therapeutic monitoring of patients treated with dabigatran etexilate by Douxfils, J, Dogné, J-M, Mullier, F, Chatelain, B, Rönquist-Nii, Y, Malmström, R E, Hjemdahl, P

    Published in Thrombosis and haemostasis (01-09-2013)
    “…Ways to monitor dabigatran etexilate (DE) therapy would be useful in certain situations. Functional assays such as aPTT or Hemoclot® Thrombin Inhibitor (HTI)…”
    Get more information
    Journal Article
  7. 7

    Influence of statin treatment on platelet inhibition by clopidogrel – a randomized comparison of rosuvastatin, atorvastatin and simvastatin co‐treatment by Malmström, R. E., Östergren, J., Jørgensen, L., Hjemdahl, P.

    Published in Journal of internal medicine (01-11-2009)
    “… Objectives.  Possible interactions between clopidogrel and atorvastatin, simvastatin or rosuvastatin (a ‘non‐CYP3A4’ metabolized statin) were investigated in…”
    Get full text
    Journal Article
  8. 8

    Endothelin attenuates endothelium-dependent platelet inhibition in man by Malmström, R.E, Settergren, M, Pernow, J

    Published in Acta Physiologica (01-04-2010)
    “…The vascular endothelium produces several substances, including nitric oxide (NO) and endothelin-1 (ET-1), which participate in the regulation of vascular tone…”
    Get full text
    Journal Article
  9. 9

    A single test to assay warfarin, dabigatran, rivaroxaban, apixaban, unfractionated heparin, and enoxaparin in plasma by Letertre, L. R., Gudmundsdottir, B. R., Francis, C. W., Gosselin, R. C., Skeppholm, M., Malmstrom, R. E., Moll, S., Hawes, E., Francart, S., Onundarson, P. T.

    Published in Journal of thrombosis and haemostasis (01-05-2016)
    “…Essentials Simple and fast assaying of different anticoagulants (ACs) is useful in emergent situations. We used highly diluted prothrombin time (dPT) or highly…”
    Get full text
    Journal Article
  10. 10

    Different initiatives across Europe to enhance losartan utilization post generics: impact and implications by Moon, James C, Godman, Brian, Petzold, Max, Alvarez-Madrazo, Samantha, Bennett, Kathleen, Bishop, Iain, Bucsics, Anna, Hesse, Ulrik, Martin, Andrew, Simoens, Steven, Zara, Corinne, Malmström, Rickard E

    Published in Frontiers in pharmacology (2014)
    “…There is an urgent need for health authorities across Europe to fully realize potential savings from increased use of generics to sustain their healthcare…”
    Get full text
    Journal Article
  11. 11

    Nitric oxide and endothelin-1 release after one-lung ventilation during thoracoabdominal esophagectomy by Lund, M., Ny, L., Malmström, R. E., Lundberg, J. O., Öst, Å., Björnstedt, M., Lundell, L., Tsai, J. A.

    Published in Diseases of the esophagus (01-11-2013)
    “…SUMMARY One‐lung ventilation (OLV) is applied during esophagectomy to improve exposure during the thoracic part of the operation. Collapse of lung tissue,…”
    Get full text
    Journal Article
  12. 12

    Neuropeptide Y Y1 receptor mechanisms in sympathetic vascular control by Malmström, R E

    “…The Y1 receptor is the predominant vascular NPY receptor subtype in pig hind limb and kidney. Thus, vascular responses to exogenous and endogenous NPY were…”
    Get more information
    Journal Article
  13. 13
  14. 14

    Characterization and molecular cloning of vascular neuropeptide Y receptor subtypes in pig and dog by Malmström, Rickard E., Hökfelt, Tomas, Björkman, Jan-Arne, Nihlén, Carina, Byström, Mona, Ekstrand, A.Jonas, Lundberg, Jan M.

    Published in Regulatory peptides (25-09-1998)
    “…Cloning with subsequent in vitro and in vivo characterization of vascular neuropeptide Y (NPY) receptor subtypes in porcine and canine peripheral tissues was…”
    Get full text
    Journal Article
  15. 15

    Existence of both neuropeptide Y, Y1 and Y2 receptors in pig spleen: evidence using subtype-selective antagonists in vivo by Malmstrom, RE

    Published in Life sciences (1973) (14-09-2001)
    “…The effects of the first selective, non-peptide, NPY Y2 receptor antagonist…”
    Get full text
    Journal Article
  16. 16

    Vascular neuropeptide Y Y1-receptors in the rat kidney: vasoconstrictor effects and expression of Y1-receptor mRNA by Modin, A., Malmström, R.E., Meister, B.

    Published in Neuropeptides (Edinburgh) (01-08-1999)
    “…Neuropeptide Y (NPY) -receptor subtypes were studied in the rat kidney in vivo by systemic administration of NPY, the two agonists [Leu 31, Pro 34]NPY…”
    Get full text
    Journal Article Conference Proceeding
  17. 17

    Neuropeptide Y Y1 receptor mediated mesenteric vasoconstriction in the pig in vivo by Malmstrom, RE

    Published in Regulatory peptides (24-11-2000)
    “…The object of the present study was to investigate the effects of the sympathetic cotransmitter neuropeptide Y (NPY), and the closely related gut hormone…”
    Get full text
    Journal Article
  18. 18

    Sex Differences in Spontaneous Reports on Adverse Drug Events for Antihypertensive Drugs by Rydberg, D.M, Mejyr, S, Loikas, D, Schenck-Gustafsson, K, von Euler, M, Malmström, R.E

    Published in Clinical therapeutics (01-08-2017)
    “…Methods A cross sectional analysis combining number of reports for ten groups of antihypertensive drugs; ACE inhibitors (ACE-I), with or without thiazide…”
    Get full text
    Journal Article
  19. 19

    Vascular pharmacology of BIIE0246, the first selective non-peptide neuropeptide Y Y(2) receptor antagonist, in vivo by Malmstrom, RE

    Published in British journal of pharmacology (01-08-2001)
    “…BIIE0246, a recently introduced non-peptide neuropeptide Y (NPY) Y(2) receptor antagonist, was pharmacologically characterized in vivo, on vascular responses…”
    Get full text
    Journal Article
  20. 20

    Neuropeptide Y accounts for sympathetic vasoconstriction in guinea-pig vena cava: evidence using BIBP 3226 and 3435 by Malmström, Richard E., Lundberg, Jan M.

    Published in European journal of pharmacology (29-12-1995)
    “…The ability of the novel, non-peptide, neuropeptide Y Y 1 receptor antagonist, BIBP 3226 (( R)- N 2-(diphenylacetyl)-…”
    Get full text
    Journal Article